CoChat

Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease

Open access
Conti, Elisa, Gregori, Maria, Radice, Isabella, Da Re, Fulvio, Grana, Denise, Re, Francesca, Salvati, Elisa, Masserini, Massimo, Ferrarese, Carlo, Zoia, Chiara Paola, Tremolizzo, Lucio · 2017 · Neurochemistry International
Cited by 45

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

&NA; The accumulation of extracellular amyloid beta (Abeta42) both in brain and in cerebral vessels characterizes Alzheimer's disease (AD) pathogenesis. Recently, the possibility to functionalize nanoparticles (NPs) surface with Abeta42 binding molecules, making them suitable tools for reducing Abeta42 burden has been shown effective in models of AD. Aim of this work consisted in proving that NPs might be effective in sequestering Abeta42 in biological fluids, such as CSF and plasma. This demonstration is extremely important considering that these Abeta42 pools are in continuum with the brain parenchyma with drainage of Abeta from interstitial brain tissue to blood vessel and plasma. In this work, liposomes (LIP) were functionalized as previously shown in order to promote high‐affinity Abeta binding, i.e., either with, phosphatidic acid (PA), or a modified Apolipoprotein E‐derived peptide (mApo), or with a curcumin derivative (TREG); Abeta42 levels were determined by ELISA in CSF and plasma samples. mApo‐PA‐LIP (25 and 250 &mgr;M) mildly albeit significantly sequestered Abeta42 proteins in CSF samples obtained from healthy subjects (p < 0.01). Analogously a significant binding (˜20%) of Abeta42 (p < 0.001) was demonstrated following exposure to all functionalized liposomes in plasma samples obtained from selected AD or Down's syndrome patients expressing high levels of Abeta42. The same results were obtained by quantifying Abeta42 content after removal of liposome‐bound Abeta by using gel filtration chromatography or ultracentrifugation on a discontinuous sucrose density gradient. In conclusion, we demonstrate that functionalized liposomes significantly sequester Abeta42 in human biological fluids. These data may be critical for future in vivo administration tests using NPs for promoting sink effect. HighlightsThe use of high affinity Abeta binding liposomes is proposed in human biological fluids.Functionalized liposomes significantly interact with Abeta in plasma and CSF from AD patients.Liposomes may exploit the Abeta “sink effect” as a potential therapeutic strategy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuint.2017.02.012

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 45

Metadata

Authors
Conti, E., Gregori, M., Radice, I., Da Re, F., Grana, D., Re, F., Salvati, E., Masserini, M., Ferrarese, C., Zoia, C. P., & Tremolizzo, L.
Venue
Neurochemistry International
Publisher
Elsevier BV
Published
2017-09
Volume
108
Pages
60-65
ISSN
0197-0186 (ISSN-L)
OpenAlex
W2589877128
Cited by
45
References
7
FWCI
3.26
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.neuint.2017.02.012
The paper
Conti, E., Gregori, M., Radice, I., Da Re, F., Grana, D., Re, F., Salvati, E., Masserini, M., Ferrarese, C., Zoia, C. P., & Tremolizzo, L. (2017). Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease. Neurochemistry International. https://doi.org/10.1016/j.neuint.2017.02.012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.